Komipharm International Company Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Komipharm International Company Limited with three other
companies in this sector in South Korea:
sales of 18.57 billion Korean Won [US$15.64 million]
of which 78%
was The clinical trial agent),
Choong Ang Vaccine Laboratory
(34.60 billion Korean Won [US$29.14 million]
Cell Biotech Co ., Limited.
(49.50 billion Korean Won [US$41.68 million]
of which 84%
was Finished Products).
Komipharm International Company Limited reported sales of 36.41 billion Korean Won (US$30.65 million)
December of 2015.
increase of 5.7%
versus 2014, when the company's sales were 34.45 billion Korean Won.
Sales at Komipharm International Company Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 100%).